title: [The risk of developing osteoporosis in rheumatic diseases].
abstract: Although osteoporosis is frequently associated with rheumatic diseases, at present it is not clear if osteoporosis is due to local factors as for example disease and inflammation, or to a systemic factor related to the rheumatic condition. In this review the present stage of knowledge on the inverse relationship between primary osteoarthritis and primary osteoporosis, bone metabolism in rheumatoid arthritis, the effect of corticosteroids on bone in rheumatoid arthritis, and preventive and curative therapy for osteoporosis is discussed.
authors: J
authors: J
authors: Dequeker
authors: A
authors: A
authors: Vertraeten
authors: D
authors: D
authors: Gevers
authors: P
authors: P
authors: Geusens
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001842:Bone and Bones / Q000378:metabolism; D002116:Calcitonin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000209:etiology* / Q000378:metabolism; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control; D012307:Risk Factors
chemical_list: D000305:Adrenal Cortex Hormones; D002116:Calcitonin
vernacular_title: Risk razvitiia osteoporoza pri revmaticheskikh zabolevaniiakh.